Impact of the variability of cyclosporin A trough levels on long-term renal allograft function

Background. Among renal allograft recipients, there is a considerable variability in cyclosporin A (CsA) trough levels. Some of he CsA metabolites are pharmacologically active. The variability of polyclonal CsA trough levels may contribute to the fact that long-term renal allograft survival is still not satisfactory. In a retrospective. single-centre study, we investigated the influence of the variability of polyclonal CsA trough levels oil long-term renal allograft function. Methods. Patients (n=381) received double immunosuppression consisting of C,A and methylprednisolone (MP). For each patient the CsA coefficient of variation (CCV) and the mean CsA trough level during the observation period (5 years) were calculated. Based on receiver operating characteristic (ROC) analysis. patients were divided into two groups: group 1. CCV <28.05%, n=231: group II, CCV >28.05%, n = 150. Additionally, patients were divided into three groups according to their mean CsA trough level: group A, <270 ng/ml, n = 50: group B, 270-370 ng/ml, n = 282: group C: >370 ng/ml, n = 49. Results. Compared to group 1, patients in group 11 experienced a higher incidence of acute rejection episodes (40.7% vs 29.4% P=0.02), reduced 5-year graft survival (81.1% vs 93.3%, P=0.002), and higher serum creatinine levels (1.7 +/- 1.2 mg/dl vs. 1.4. +/- 0.5 mg/dl, P=0.03). In patients with low mean CsA trough levels, the incidence of acute rejection episodes was elevated (group A vs B. 50.0% vs 30.9%, P=0.008) and 5-year graft survival was reduced (group A vs B 79.8% vs 89.5%, P=0.005). Multiple logistic regression analysis confirmed that the risk of graft failure within 5 years after transplantation was markedly elevated in group II (RR: 6.2. P=0.013) and in group A (RR: 8.9. P=0.008), Whereas the effect of CCV on 5-year graft survival was still evident in patient,, with normal or high mean CsA trough levels (>270 ng/ml. 81.9% vs 94.8%, P=0.0005), graft Survival as independent from CCV in patients with low mean CsA though levels (<270 ng/ml, 77.0% vs 81.7% P=NS), Conclusions. Both. the intra-individual variability and the mean of polyclonal CsA trough levels influence long-term renal allograft survival. Targeting at sufficiently high mean CsA levels, with a low intra-individual variability may help to further improve long-term renal allograft survival.